Highbridge Capital Management’s Cytokinetics CYTK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q3 | – | Sell |
-25,910
| Closed | -$314K | – | 848 |
|
|
2017
Q2 | $314K | Buy |
+25,910
| New | +$314K | ﹤0.01% | 657 |
|
|
2016
Q4 | – | Sell |
-59,075
| Closed | -$543K | – | 1054 |
|
|
2016
Q3 | $543K | Buy |
+59,075
| New | +$543K | 0.01% | 650 |
|
|
2016
Q1 | – | Sell |
-75,874
| Closed | -$793K | – | 871 |
|
|
2015
Q4 | $793K | Buy |
+75,874
| New | +$793K | 0.01% | 486 |
|
|
2015
Q2 | – | Sell |
-110,169
| Closed | -$746K | – | 874 |
|
|
2015
Q1 | $746K | Buy |
110,169
+93,367
| +556% | +$632K | 0.01% | 522 |
|
|
2014
Q4 | $135K | Sell |
16,802
-105,430
| -86% | -$847K | ﹤0.01% | 693 |
|
|
2014
Q3 | $431K | Buy |
122,232
+98,738
| +420% | +$348K | 0.01% | 653 |
|
|
2014
Q2 | $112K | Buy |
+23,494
| New | +$112K | ﹤0.01% | 684 |
|
|
2014
Q1 | – | Sell |
-22,639
| Closed | -$148K | – | 749 |
|
|
2013
Q4 | $148K | Sell |
22,639
-22,397
| -50% | -$146K | ﹤0.01% | 639 |
|
|
2013
Q3 | $342K | Buy |
45,036
+30,588
| +212% | +$232K | ﹤0.01% | 748 |
|
|
2013
Q2 | $167K | Buy |
+14,448
| New | +$167K | ﹤0.01% | 850 |
|